A recent study in JAMA shows Peritumoral Radiomics may provide additional predictive value for treatment response in esophageal Cancer patients- benefiting individualized therapeutic strategies and personalized care.
Intrigued? Let's talk and find out what's important to you
Once we understand your needs we can customize a demo specifically for you and your team